Tarceva 100mg, 150mg (Tablet) Erlotinib
Intended for healthcare professionals only
This material should not be used as a substitute for professional medical advice or to promote any medication. For more information, please consult your physician
Avastin (Bevacizumab) injection is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). It is indicated for adult patients with metastatic colorectal cancer, unresectable, locally advanced, recurrent or metastatic non–squamous non–small cell lung cancer (NSCLC), recurrent glioblastoma, metastatic renal cell carcinoma, persistent, recurrent, or metastatic cervical cancer, patients with stage III or IV epithelial ovarian, fallopian tube, or primary peritoneal cancer following initial surgical resection, either alone or in combination with chemotherapies.
Full prescribing information is available on request.
If you have a scientific query related to one of Roche's products, please contact us at [email protected]
In case of any adverse events or safety queries, please contact [email protected]
M-PK-00002297
Solutions
Pharma Products
![[Product] Tarceva](https://assets.roche.com/f/169232/768x511/cbecebb7ea/tarceva.jpg/m/320x180/filters:format(webp):quality(90)/)